E. Serna

发表

Zanthoxylum chiloperone leaves extract: first sustainable Chagas disease treatment.

A. Rojas de Arias, M. Rolón, A. Fournet, 2011, Journal of ethnopharmacology.

Identification of a New Amide-Containing Thiazole as a Drug Candidate for Treatment of Chagas' Disease

Marcelo Fernández, H. Cerecetto, J. Varela, 2014, Antimicrobial Agents and Chemotherapy.

Preclinical Studies in Anti-Trypanosomatidae Drug Development

S. Wilkinson, C. Robello, Ileana Corvo, 2021, Pharmaceuticals.

3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies.

A. López de Cerain, Diego Benítez, A. Monge, 2011, Journal of medicinal chemistry.

Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity

R. Pérez-Montfort, A. Gómez-Puyou, A. Merlino, 2016, ChemMedChem.

In Vivo Anti-Trypanosoma cruzi Activity of Hydro-Ethanolic Extract and Isolated Active Principles from Aristeguietia glutinosa and Mechanism of Action Studies

H. Cerecetto, J. Varela, Mercedes González, 2014, Molecules.

Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity.

M. Chorilli, H. Cerecetto, J. Varela, 2014, Journal of medicinal chemistry.

2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents.

A. Rojas de Arias, A. Gómez-Barrio, A. Denicola, 2006, Journal of medicinal chemistry.

In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles.

A. Rojas de Arias, V. Arán, H. Cerecetto, 2009, European journal of medicinal chemistry.

Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice.

A. Fournet, R. Hocquemiller, E. Poupon, 2007, Journal of ethnopharmacology.

Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease

H. Cerecetto, L. Minini, Guzmán Álvarez, 2022, Pharmaceuticals.

Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.

R. Pérez-Montfort, Beatriz Aguirre-López, N. Cabrera, 2015, European journal of medicinal chemistry.

Quantitative Changes in Rat Seminiferous Epithelium After Chronic Administration of Low Doses of Cadmium and Zinc: A Stereological Study

Rocío Martín, L. Santamaría, I. Ingelmo, 2010 .

IN VIVO ANTILEISHMANIAL EFFICACY OF COMBRETASTATIN HETEROANALOGUES

M. Ferreira, M. Maldonado, E. Caballero, 2009 .

A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids

C. Robello, Ileana Corvo, Guzmán Álvarez, 2019, Molecules.

Helietta apiculata: a tropical weapon against Chagas disease

A. Rojas de Arias, A. Torrecilhas, A. Fournet, 2019, Natural product research.

Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.

R. Pérez-Montfort, Beatriz Aguirre-López, N. Cabrera, 2015, European journal of medicinal chemistry.